Article
Public (all visitors)
FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease | Berkeley News
Berkeley News
2021
UC scientists and physicians hope to permanently cure patients of sickle cell disease by using CRISPR-Cas9 to replace a defective gene with the normal version
Browse more
View all ArticlesContribute to FoundryBase
Found something worth adding?
Sign in to suggest resources and start building your own collection.